Health

Guidelines advise no screening after age 70, and doctors say that even men who test diligently may develop an aggressive

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of

The procedure could be life-changing for some people with debilitating conditions.

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market

The most extensive research on Medicaid coverage to date found that it reduced the risk of death by 21 percent.

New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be

So-called transient ischemic attacks can eventually lead to cognitive declines as steep as those following a full-on stroke, new research

N.I.H. restrictions on payments to foreign partners may jeopardize research into conditions that would benefit Americans.